Results 171 to 180 of about 21,433,686 (207)
Some of the next articles are maybe not open access.
Treatment of chronic hepatitis C
Journal of Hepatology, 1991alpha-Interferon given subcutaneously at doses between 1-3 million units leads to responses in about 50% of patients suffering from chronic hepatitis C. A 24-week treatment is frequently (approx. 50%) followed by relapses reducing the percentage of lasting responders to approx. 20%.
openaire +2 more sources
Therapy for chronic hepatitis C
Journal of Physiology-Paris, 2001in Hungary, over the past 5 years more than 900 patients with chronic hepatitis C have been examined for treatment with interferon at 16 major hepatology centres, using unified diagnostic and therapeutical criteria. Authors give an account of their experiences on the clinical features of patients with chronic hepatitis C and report the results of the ...
Pár, Alajos +3 more
openaire +3 more sources
Hepatitis C virus genotypes in chronic hepatitis C of children
Journal of Viral Hepatitis, 1996SUMMARY.Several hepatitis C virus (HCV) genotypes have been recently identified and genotype 1b has been correlated with severe liver disease and a poor response to interferon therapy. HCV infection in children is an interesting model for evaluation of the relationship between HCV genotypes and liver disease, because of its relatively short duration ...
BORTOLOTTI, FLAVIA +10 more
openaire +5 more sources
Treatment for chronic hepatitis C
Current Gastroenterology Reports, 2003Approximately four million Americans have been exposed to the hepatitis C virus (HCV) and are anti-HCV positive; almost three million are chronically infected and HCV RNA positive. Treatment for chronic hepatitis C has improved rapidly over the past 12 years from interferon monotherapy, with a sustained virologic response (SVR) rate of about 10% in the
openaire +2 more sources
Hepatic sarcoidosis associated with chronic hepatitis C
Journal of Gastroenterology, 2002A 57-year-old woman with sarcoidosis was referred because of the appearance of multiple small low-attenuation areas in the liver on computed tomography (CT). A liver biopsy specimen showed chronic active hepatitis accompanied by sarcoid granulomas. The patient received prednisolone and, later, interferon-alpha.
Shinwa, Yamada +5 more
openaire +2 more sources
Economics of chronic hepatitis B and hepatitis C
Journal of Hepatology, 2007Although not all patients develop progressive liver disease, chronic hepatitis B and chronic hepatitis C infections cause substantial morbidity and mortality worldwide. To address this need, many new antiviral treatments have become available over the past 10 years.
Arathi, Rajendra, John B, Wong
openaire +2 more sources
Antifibrotics for Chronic Hepatitis C
Clinics in Liver Disease, 2009Development and testing of antifibrotic agents for the treatment of chronic hepatitis C have generally been targeted toward hepatic stellate cells, transforming growth factor-beta, the inflammatory response, or extracellular matrix accumulation. Although several agents such as interferon-gamma, long-term pegylated interferon, and caspase inhibitors ...
openaire +2 more sources
Disease-a-Month, 1994
Formerly the diagnosis of acute and chronic non-A, non-B hepatitis was made by the exclusion of other causes. However, in 1989 cloning of an antigenic component of the hepatitis C virus (HCV) was reported. This led to first- and second-generation tests for antibody to HCV (anti-HCV) in serum.
openaire +3 more sources
Formerly the diagnosis of acute and chronic non-A, non-B hepatitis was made by the exclusion of other causes. However, in 1989 cloning of an antigenic component of the hepatitis C virus (HCV) was reported. This led to first- and second-generation tests for antibody to HCV (anti-HCV) in serum.
openaire +3 more sources
BMJ clinical evidence, 2018
About 60% to 85% of people infected with hepatitis C virus will go on to develop chronic hepatitis C, which is now believed to affect 3% of the world's population.We conducted a systematic overview and aimed to answer the following clinical questions: What are the effects of interferon-free treatments in treatment-naïve people with chronic hepatitis C ...
Alan Hoi Lun, Yau +2 more
openaire +1 more source
About 60% to 85% of people infected with hepatitis C virus will go on to develop chronic hepatitis C, which is now believed to affect 3% of the world's population.We conducted a systematic overview and aimed to answer the following clinical questions: What are the effects of interferon-free treatments in treatment-naïve people with chronic hepatitis C ...
Alan Hoi Lun, Yau +2 more
openaire +1 more source